Skip to main content

Table 4 Joint typologies (acceptability) and statistics (adherence) display

From: Personalising psychotherapies for depression using a novel mixed methods approach: an example from Morita therapy

Typology of acceptability

Trial ID

Therapy sessions, number

Reason for withdrawing from treatment (N/A = completed treatment)

Treatment response?a

Each

Mean

(1) Principles: unacceptable (incompatibility with expectations/ hopes for treatment);

process/practice: unacceptable (treatment-related challenges)

MT61

3

5

Discomfort with writing about self in diary; failure of rest to meet expected purpose

No

MT19

5

Pressure of completing phases in absence of therapy fulfilling expected purpose

No

MT51

5

Lack of techniques provided; challenges of rest in context of not fulfilling expected purpose

No

MT28

7

Pressure of completing phases in absence of therapy fulfilling expected purpose

No

(2) Principles: mixed views (limited identification with principles);

process/practice: mixed views (treatment related and non-treatment related challenges; insurmountable)

MT54

1

N/A

Time difficulties (rest/diary); difficulties with Fumon (therapists’ inattention to symptoms)

Yes (attributed to life changes)

(3) Principles: mixed views (limited identification with principles);

process/practice: acceptable (some challenges; tolerated/worthwhile)

MT58

9

N/A

N/A

No

(4) Principles: acceptable (strong identification with principles);

process/practice: mixed views (treatment related and non-treatment related challenges; insurmountable)

MT17

2

3.5

Time difficulties (rest)

No

MT50

2

Safety issues (personal relationships) during rest

Yes

MT15

3

Time difficulties (rest); no longer felt need for therapy

Yes

MT37

7

Time difficulties (attending sessions); no longer felt need for therapy

Yes

(5) Principles: acceptable (strong identification with principles);

process/practice: acceptable (some challenges; tolerated/ worthwhile)

MT33

9

10.8

N/A

Yes

MT63

10

N/A

Yes

MT45

11

N/A

Yes

MT55

11

N/A

Yes

MT16

12

N/A

Yes

MT43

12

N/A

Yes

  1. N/A not applicable
  2. aTreatment response defined as ≥ 50% reduction in depressive symptoms (Patient Health Questionnaire-9 (PHQ-9)) from baseline to follow up